Characterization of a new Leishmania major strain for use in a controlled human infection model

Leishmaniasis is widely regarded as a vaccine-preventable disease, but the costs required to reach pivotal Phase 3 studies and uncertainty about which candidate vaccines should be progressed into human studies significantly limits progress in vaccine development for this neglected tropical disease....

Descripción completa

Detalles Bibliográficos
Autores principales: Ashwin, Helen, Sadlova, Jovana, Vojtkova, Barbora, Becvar, Tomas, Lypaczewski, Patrick, Schwartz, Eli, Greensted, Elizabeth, Van Bocxlaer, Katrien, Pasin, Marion, Lipinski, Kai S., Parkash, Vivak, Matlashewski, Greg, Layton, Alison M., Lacey, Charles J., Jaffe, Charles L., Volf, Petr, Kaye, Paul M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801518/
https://www.ncbi.nlm.nih.gov/pubmed/33431825
http://dx.doi.org/10.1038/s41467-020-20569-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801518/
https://www.ncbi.nlm.nih.gov/pubmed/33431825
http://dx.doi.org/10.1038/s41467-020-20569-3

Ejemplares similares